BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanda Y, Shigeno K, Kinoshita N, Nakao K, Yano M, Matsuo H. Sudden hearing loss associated with interferon. Lancet. 1994;343:1134-1135. [PMID: 7910234 DOI: 10.1016/S0140-6736(94)90237-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Sharifian MR, Kamandi S, Sima HR, Zaringhalam MA, Bakhshaee M. INF- α and ototoxicity. Biomed Res Int 2013;2013:295327. [PMID: 23984336 DOI: 10.1155/2013/295327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
2 Sleijfer S, Bannink M, Van Gool AR, Kruit WH, Stoter G. Side effects of interferon-alpha therapy. Pharm World Sci. 2005;27:423-431. [PMID: 16341948 DOI: 10.1007/s11096-005-1319-7] [Cited by in Crossref: 129] [Cited by in F6Publishing: 116] [Article Influence: 8.1] [Reference Citation Analysis]
3 Elloumi H, Houissa F, Hadj NB, Gargouri D, Romani M, Kharrat J, Ghorbel A. Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment. World J Gastroenterol 2007; 13(40): 5411-5412 [PMID: 17879419 DOI: 10.3748/wjg.v13.i40.5411] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
4 Henkin RI. Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf 1994;11:318-77. [PMID: 7873092 DOI: 10.2165/00002018-199411050-00004] [Cited by in Crossref: 124] [Cited by in F6Publishing: 96] [Article Influence: 4.6] [Reference Citation Analysis]
5 Liu J, Chen H, Lin X, Yi J, Ye W, Wei F, Zhu X, Huang J, Su J. Age-related Activation of Cyclic GMP-AMP synthase-Stimulator of Interferon Genes Signaling in the Auditory System is Associated with Presbycusis in C57BL/6J Male Mice. Neuroscience 2022;481:73-84. [PMID: 34848262 DOI: 10.1016/j.neuroscience.2021.11.031] [Reference Citation Analysis]
6 Gervais A, Boyer N, Marcellin P. Tolerability of treatments for viral hepatitis. Drug Saf 2001;24:375-84. [PMID: 11419564 DOI: 10.2165/00002018-200124050-00004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tanaka M, Hasegawa S, Nakao S, Shimada K, Mukai R, Matsumoto K, Nakamura M. Analysis of drug-induced hearing loss by using a spontaneous reporting system database. PLoS One 2019;14:e0217951. [PMID: 31593579 DOI: 10.1371/journal.pone.0217951] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
8 Sposato LA, Fustinoni O. Iatrogenic neurology. Handb Clin Neurol 2014;121:1635-71. [PMID: 24365439 DOI: 10.1016/B978-0-7020-4088-7.00107-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]